Ashfield is pleased to be featured in the Pharma Voice March Issue.
Editor Robin Robinson reports on how the changes in the life sciences marketplace are reshaping the traditional sales role in her article “Preparing for an Outcomes-based Sales Model”. She draws upon the expertise of several industry leaders to flesh out her thesis, including Wendy Wolf, Senior VP US Commercial Operations, Ashfield.
Wendy Wolf explains, “Outcomes are driving choice more than ever before. The bottom line is always the value equation for physicians: does a brand bring value to my practice, my staff and my patients? Is it going to bring more value than the competition, even when the competition is generic and is pennies on the dollar vs. the branded drug?”
Ms Wolf shares her thoughts in the latest edition of Pharma Voice.